Spots Global Cancer Trial Database for The Rechallenge of ADCs in MBC Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Rechallenge of ADCs in MBC Patients
Official Title: A Multicenter, Real-world Study of the Efficacy and Safety of Antibody-drug Conjugates (ADCs) Rechallenge in Patients With Prior Exposure to ADCs Metastatic Breast Cancer
Study ID: NCT05571618
Conditions
Interventions
Study Description
Brief Summary: To investigate the efficacy and safety of ADC rechallenge
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
